Precision Biosciences (DTIL) Prepaid Assets (2018 - 2026)
Precision Biosciences (DTIL) reported Prepaid Assets of $3.5 million for Q1 2026, up 2919.83% year-over-year from $116000.0 in Q1 2025, and up 12.64% quarter-over-quarter from $3.1 million in Q4 2025.
Precision Biosciences (DTIL) Prepaid Assets (2018 - 2026) Analysis & Trends
Precision Biosciences (DTIL) has 9 years of Prepaid Assets data on file, last reported at $3.5 million in Q1 2026.
- Prepaid Assets for Q1 2026 came in at $3.5 million, up 2919.83% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.5 million (up 2919.83% YoY), and the FY2025 annual result was $3.1 million, up 742.82% from the prior year.
- Prepaid Assets advanced to $3.5 million in Q1 2026 per DTIL's latest filing, from $3.1 million in the prior quarter.
- Over five years, Prepaid Assets peaked at $12.6 million in Q2 2022 and troughed at $116000.0 in Q1 2025.
- A 5-year average of $3.2 million and a median of $790000.0 in 2024 frame the typical range for Prepaid Assets.
- The sharpest annual moves came in 2025 and 2026: Prepaid Assets sank 98.75% in 2025, then surged 2919.83% in 2026.
- A 5-year view of Prepaid Assets shows it stood at $6.0 million in 2022, then plunged by 93.05% to $419000.0 in 2023, then slipped by 11.93% to $369000.0 in 2024, then surged by 742.82% to $3.1 million in 2025, then grew by 12.64% to $3.5 million in 2026.
- Business Quant data shows DTIL's Prepaid Assets at $3.5 million in Q1 2026, $3.1 million in Q4 2025, and $5.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Precision Biosciences | 168.99 Mn | 67.81 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.50 Mn |
| Dec 31, 2025 | 3.11 Mn |
| Sep 30, 2025 | 5.86 Mn |
| Jun 30, 2025 | 427,000.00 |
| Mar 31, 2025 | 116,000.00 |
| Dec 31, 2024 | 369,000.00 |
| Sep 30, 2024 | 471,000.00 |
| Jun 30, 2024 | 790,000.00 |
| Mar 31, 2024 | 9.25 Mn |
| Dec 31, 2023 | 419,000.00 |
| Sep 30, 2023 | 349,000.00 |
| Jun 30, 2023 | 8.92 Mn |
| Mar 31, 2023 | 1.77 Mn |
| Dec 31, 2022 | 6.03 Mn |
| Sep 30, 2022 | 307,000.00 |
| Jun 30, 2022 | 12.63 Mn |
| Mar 31, 2022 | 283,000.00 |
| Dec 31, 2021 | 17.43 Mn |
| Sep 30, 2021 | 898,000.00 |
| Jun 30, 2021 | 5.42 Mn |